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Abstract The Caldariomyces fumago chloroperoxidase (CPO)
is synthesised as a 372-aa precursor which undergoes two
proteolytic processing events: removal of a 21-aa N-terminal
signal peptide and of a 52-aa C-terminal propeptide. The
Aspergillus niger expression system developed for CPO was
used to get insight into the function of this C-terminal propeptide.
A. niger transformants expressing a CPO protein from which the
C-terminal propeptide was deleted failed in producing any
extracellular CPO activity, although the CPO polypeptide was
synthesised. Expression of the full-length gene in an A. niger
strain lacking the KEX2-like protease PclA also resulted in the
production of CPO cross-reactive material into the culture
medium, but no CPO activity. Based on these results, a function
of the C-terminal propeptide in CPO maturation is indi-
cated. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Chloroperoxidase (CPO) is a glycosylated haemoprotein se-
creted by the fungus Caldariomyces fumago [1,2]. In vivo, this
enzyme is involved in the synthesis of caldariomycin, a halo-
genated compound with antimicrobial function [3]. In vitro,
CPO catalyses a number of useful chemical reactions such as
enantioselective oxygen-transfer reactions, H2O2 dispropor-
tionations and oxidative halogenations [4].
The molecular genetics of the C. fumago CPO has been
extensively characterised by Hager and co-workers. The pro-
tein is encoded by a single-copy gene [5] and CPO synthesis is
controlled at the mRNA level, fructose being an inducing and
glucose a repressing carbon-source [6]. The gene product
undergoes a number of post-translational modi¢cations [7].
A 21-aa signal sequence is removed from the CPO precursor
and the resulting N-terminal glutamic acid is converted into a
pyroglutamic acid. Carbohydrate moieties are incorporated at
N- and O-glycosylation sites. Di¡erent isozymes are found in
the extracellular medium of C. fumago cultures [8,9], which
are indicated to be glycosylation variants of the same poly-
peptide [2,7]. In the major CPO isozyme, the most heavily
glycosylated, three N- and 11 O-glycosylation sites are occu-
pied with a total of 21 sugar groups [10]. Other modi¢cations
include deamidation of three amidic residues to the corre-
sponding acids [7], one disul¢de bond formation and the in-
corporation of a protoporphyrin XI (haem b) molecule [10].
Resolution of the crystal structure of the mature protein has
shown that the haem pocket in CPO shares features of both
classical peroxidases and cytochrome P450s. At the proximal
site of the haem pocket, the haem is coordinated via a thiolate
ligand to a cysteine, resembling the cytochrome P450, whereas
at the distal site, polar residues are found similar to other
haem peroxidases [10]. The crystal structure also revealed
that the last 52 aa of the primary translation product are
lacking in the mature protein, suggesting that CPO also
undergoes proteolytic processing at the C-terminus. This pro-
cessing apparently occurs downstream of a dibasic (KR) pro-
cessing site [10].
C-terminal propeptides are found in intracellular and se-
creted proteins and, although in many cases no function has
been ascribed to these sequences, they have been suggested to
participate in processes such as protein folding, targeting and
secretion (for examples see [11^17]). The function of the C-
terminal propeptide of CPO is completely unknown. Here, we
describe approaches to get more insight into the function of
the CPO C-terminal propeptide using the Aspergillus niger
expression system recently developed for CPO [18].
2. Materials and methods
2.1. Expression cassettes
Fig. 1 shows the expression cassettes used in this study. Construc-
tion of pCPO3.I-AmdS is described previously [18]. Expression vector
pCPOv-AmdS which contains the cpo translation product lacking
most of the C-terminal propeptide, was constructed by amplifying
the corresponding sequence in the cpo gene present in pCf6 (kindly
provided by Dr. Hager, University of Illinois at Urbana-Champaign)
with primers CLP15E/A (5P-GGAATTCACATGTTCTCCAAGG-
TCC-3P) and CLP3B/H (5P-CGGGATCCAAGCTTCCCATGGAG-
GTGGTGG-3P). The ampli¢cation product was digested with A£III/
HindIII and cloned into the pAN52-10Not Aspergillus expression vec-
tor (carrying the A. niger glaA promoter; Punt, unpublished) at the
NcoI/HindIII cloning sites. After con¢rming the ampli¢ed fragment
by sequencing, the Aspergillus nidulans AmdS selection marker [19]
was introduced as a 4.5-kb NotI fragment at the unique NotI site of
the resulting vector.
2.2. Fungal strains and transformation procedures
A. niger MGG029 (prtT, gla: :£eor, pyrG ; [20]) and A. niger
AB1.13-vpclA (pclA: :pyrGmut, prtT, pyrG ; Punt et al., unpublished)
were used a recipient strains in transformation experiments. AmdS/
pyrG-based fungal transformations were carried out as described [18].
2.3. Plate assays
Transformants were analysed for CPO production by means of the
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o-anisidine plate assay [18], and in situ immunodetection using sand-
wich cultures as described [21]; strains were grown between two poly-
carbonate ¢lters on plates containing Aspergillus minimal medium
[22]. After 24-h incubation at 30‡C, a polyvinylidene £uoride
(PVDF) membrane, previously activated with methanol and rinsed
with sterile distilled water, was placed between the agar surface and
the polycarbonate sandwich and the plates were incubated for another
24 h. The PVDF membrane, harbouring secretion proteins, was sub-
sequently removed, rinsed with water and subjected to immunodetec-
tion.
2.4. Shake-£ask experiments
Strains were grown from conidial inocula in 300 ml shake-£asks
containing 50 ml AMM-maltose [20]. Medium samples were taken
at 24, 48 and 72 h after inoculation and analysed for CPO activity
using the standard monochlorodimedon (MCD)-halogenating reac-
tion [3] and for CPO protein production by Western blotting [23]
using a CPO polyclonal antiserum [18].
3. Results and discussion
To study the production of the C. fumago CPO in A. niger,
we ¢rst constructed an expression vector based on the se-
quence information present in GenBank (accession number
X04486). Later sequencing data revealed a mistake in the
published cpo sequence (an extra C at position 1030, close
to the putative stop codon). Removal of the extra nucleotide
caused a shift in the reading frame, resulting in a translational
product 52 aa longer than previously deduced (accession num-
ber AJ300448). Comparison of the newly deduced sequence
with that available from the determination of the CPO crystal
structure [10] showed that the last 52 aa were not present in
the mature protein, indicating that these form a C-terminal
propeptide which is removed somewhere in the secretion path-
way. As a consequence of this sequence error, our CPO ex-
pression vector, now termed pCPOv-AmdS, lacked most of
the C-terminal propeptide (41 aa), and a new CPO expression
vector, pCPO3.I-AmdS, containing the full-length cpo se-
quence, was generated for our expression studies [18]. How-
ever, pCPOv-AmdS was used to study the function of this
prosequence using the A. niger expression system. Interest-
ingly, analysis of the C-terminal propeptide sequence showed
the presence of two basic amino acid residues (KR) directly
upstream of the processing site. As this motif resembles the
recognition sequence for cleavage by Golgi-located protein
convertases such as the KEX2 protease [24], we also studied
the production of CPO in an A. niger strain in which the gene
encoding this type of protease, termed pclA, was deleted. This
strain, A. niger AB1-13-vpclA, although it shows a compact
growth phenotype, retains the wild-type secretion capacity
(Punt et al., unpublished) and was shown to secrete active
Phanerochaete chrysosporium manganese peroxidase (MnP)
when transformed with the MnP expression vector pMnP1.I
([20] and results not shown).
A. niger MGG029, the production strain used for expres-
sion of the full-length CPO [18], was transformed with
pCPOv-AmdS, encoding the C-terminal deletion form of
CPO, and A. niger AB1.13-v-pclA was transformed with the
full-length CPO construct pCPO3.I-AmdS. Transformants
were selected by their ability to grow and sporulate on
acetamide-containing agar plates and were screened for
secretion of active CPO using the o-anisidine plate assay.
A. niger MGG029 transformants expressing the full-length
CPO construct developed a purple halo in this assay
[18]. No colour formation was visible for any of the analysed
MGG029[pCPOv-AmdS] and AB1.13-vpclA[pCPO3.I-AmdS]
transformants, indicating the absence of extracellular peroxi-
dase activity in these strains. To study whether these trans-
formants secreted any CPO protein at all, we used the sand-
wich mode of culture, as described [21], to monitor protein
secretion in situ. This method has shown to be useful
in detecting secretion of heterologous proteins that are
rapidly degraded in the extracellular medium [25]. Using this
technique, KCPO cross-reactive material could be detected
at the place of colony growth of MGG029[pCPO3.I-AmdS]-,
MGG029[pCPOv-AmdS]- and AB1.13-vpclA- [pCPO3.I-
AmdS]-containing transformants. No cross-reactivity was ob-
served for the parental strains MGG029 and AB1.13-vpclA.
The results of both activity and secretion analysis are summa-
rised in Table 1. From this result, we concluded that the
CPO was synthesised and secreted in the three types of trans-
formants and we selected the representative strains
Fig. 1. Expression cassettes. PglaA : A. niger glucoamylase promoter; TtrpC: A. nidulans tryptophan terminator, cpo : CPO, sscpo : signal se-
quence CPO (21 aa); C-pro: C-terminal propeptide (52 aa); KR: splicing site for the C-terminal propeptide; AmdS : A. nidulans acetamidase
selection marker; D : stop codon.
Table 1
Analysis of CPO production in A. niger strains MGG029 and
AB1.13-vpclAa
Expression cassette MGG029 AB1.13-vpclA
secretionb activity secretion activity
pCPO3.I-AmdS + + + -
pCPOv-AmdS + - ndc nd
pMnP1.I + + + +
aCPO production was determined for at least four transformants
per expression cassette. In all cases co-transformation with pAB4-1,
carrying the pyrG selection marker, was carried out.
bSecretion and activity of CPO was determined on agar plates by in
situ immunodetection and o-anisidine test respectively (for details
see Section 2).
cnd, not determined.
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MGG029[pCPO-AmdS]#3 and AB1.13-vpclA[pCPO3.I-Amd-
S]#A3 together with the previously characterised MGG029-
[pCPO3.I-AmdS]#5 [18] to further analyse CPO production in
liquid medium.
Under inducing conditions, strain MGG029[pCPO3.I-
AmdS]#5 secretes active recombinant CPO (rCPO) into the
extracellular medium [18]. Accordingly, when grown in shake-
£asks containing maltose as the carbon source, CPO activity
(MCD halogenation, [3]) was observed in the culture broth of
strain MGG029[pCPO3.I-AmdS]#5 and rCPO was readily
detected by Western blotting as a strong band, migrating
slightly slower than native CPO (nCPO; Fig. 2, lanes 1 and
6). Con¢rming the results of the plate assays, no MDC-halo-
genating activity was present in the extracellular medium of
strains MGG029[pCPOv-AmdS]#3 or AB1.13-vpclA[pC-
PO3.I-AmdS]#A3. However, both strains showed multiple
KCPO cross-reactive bands when analysed by SDS^PAGE
(Fig. 2, lanes 2 and 4). In particular, in strain AB1.13-vpclA-
[pCPO3.I-AmdS]#A3, the CPO cross-reactive material ap-
peared as an intense smear (Fig. 2, lane 4). As the CPO pro-
tein synthesised in MGG029[pCPOv-AmdS]#3 lacks most of
the C-terminal propeptide, we concluded from these results
that this sequence is required to ensure the production of
active rCPO in A. niger.
Also, a non-active CPO polypeptide is secreted in trans-
formant AB1.13-vpclA[pCPO3.I-AmdS]#A3. Strain AB1.13-
vpclA lacks the KEX2-like protease PclA, which in A. niger is
known to be responsible for cleavage of the glucoamylase
propeptide (Punt et al., unpublished). Expression of the full-
length CPO construct in this strain resulted in secretion of an
inactive CPO, suggesting that the PclA protease is also in-
volved in the maturation of the CPO polypeptide. As a dibasic
site (KR), similar to the PclA recognition motif, is present at
the site of processing of the C-terminal propeptide, we postu-
late that PclA is directly involved in the cleavage of this se-
quence. A possible explanation for the results obtained in
these experiments is that the C-terminal propeptide in CPO
is required to ensure correct protein maturation, whereas its
removal at a later stage during secretion is required to yield an
active CPO protein. The C-terminal sequence may thus be
considered to have a chaperone-like function for the CPO
protein. The SDS^PAGE migrating behaviour of CPO in
MGG029[pCPOv-AmdS]#3 and AB1.13-vpclA[pCPO3.I-
AmdS]#A3 as multiple or di¡use bands is not exactly under-
stood. These multiple bands could originate from aggregation,
heterogeneous glycosylation and/or incorrect processing of the
incorrectly maturated CPO polypeptide. Addition of haem in
the culture medium, which increases the yield of CPO in wild-
type strains producing full-length CPO [18], did not result in
secretion of an active CPO in either MGG029[pCPOv-
AmdS]#3 or AB1.13-vpclA[pCPO3.I-AmdS]#A3 (results not
shown), suggesting that these strains do not secrete CPO mol-
ecules capable of activation by exogenous haem.
C-terminal propeptides have been identi¢ed for a number of
secretory proteins. For example, bacterial proteases such as
the Serratia marcescens serine protease (SSP) and the Thermus
thermophilus aqualysin I are synthesised as large precursors
with removeable of sequences at both N- and C-termini.
The C-terminal pro-region in the SSP has shown to have
di¡erent functional domains that function in protein folding
and secretion [12], whereas the aqualysin I C-terminal propep-
tide may have a role in stabilising an unfolded conformation
to facilitate translocation across the cell membrane [14]. These
C-terminal sequences, however, are much longer than that of
the C. fumago CPO and no structural relation is evident from
sequence comparison. Interestingly, C-terminal propeptides
have been reported for the horseradish peroxidase [26,27]
and several fungal laccases ([28,29] and references therein),
and the existence of a C-terminal propeptide in the Curvularia
inaequalis vanadium CPO has been also postulated [30]. The
biological function of these sequences has not been investi-
gated at an experimental level, although for the vanadium
chloroperoxide propeptide, a role in secretion has been sug-
gested [30]. The CPO C-terminal propeptide also shows no
sequence homology with any of these peptides. Our results,
however, indicate a role of this C-terminal sequence in pro-
viding CPO with its active conformation. To establish the
mechanism in which this would operate and whether there is
any interaction with the incorporation of the haem prosthetic
group needs further research.
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